BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 20047709)

  • 1. Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB.
    Laje G; Cannon DM; Allen AS; Klaver JM; Peck SA; Liu X; Manji HK; Drevets WC; McMahon FJ
    Int J Neuropsychopharmacol; 2010 Jul; 13(6):715-24. PubMed ID: 20047709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography quantification of serotonin transporter binding in medication-free bipolar disorder.
    Miller JM; Everett BA; Oquendo MA; Ogden RT; Mann JJ; Parsey RV
    Synapse; 2016 Jan; 70(1):24-32. PubMed ID: 26426356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder.
    Cannon DM; Ichise M; Rollis D; Klaver JM; Gandhi SK; Charney DS; Manji HK; Drevets WC
    Biol Psychiatry; 2007 Oct; 62(8):870-7. PubMed ID: 17678634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin transporter polymorphisms (SLC6A4 insertion/deletion and rs25531) do not affect the availability of 5-HTT to [11C] DASB binding in the living human brain.
    Murthy NV; Selvaraj S; Cowen PJ; Bhagwagar Z; Riedel WJ; Peers P; Kennedy JL; Sahakian BJ; Laruelle MA; Rabiner EA; Grasby PM
    Neuroimage; 2010 Aug; 52(1):50-4. PubMed ID: 20406689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.
    Meyer JH; Houle S; Sagrati S; Carella A; Hussey DF; Ginovart N; Goulding V; Kennedy J; Wilson AA
    Arch Gen Psychiatry; 2004 Dec; 61(12):1271-9. PubMed ID: 15583118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of the serotonin transporter gene promoter polymorphism (5-HTTLPR) genotype and serotonin transporter binding to neural processing of negative emotional stimuli.
    Schneck N; Miller JM; Delorenzo C; Kikuchi T; Sublette ME; Oquendo MA; Mann JJ; Parsey RV
    J Affect Disord; 2016 Jan; 190():494-498. PubMed ID: 26561939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the impact of BDNF Val66Met genotype on serotonin transporter and serotonin-1A receptor binding.
    Kraus C; Baldinger P; Rami-Mark C; Gryglewski G; Kranz GS; Haeusler D; Hahn A; Wadsak W; Mitterhauser M; Rujescu D; Kasper S; Lanzenberger R
    PLoS One; 2014; 9(9):e106810. PubMed ID: 25188405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking moderates association of 5-HTTLPR and in vivo availability of serotonin transporters.
    Smolka MN; Reimold M; Kobiella A; Reischl G; Rietschel M; Heinz A
    Eur Neuropsychopharmacol; 2019 Dec; 29(2):171-178. PubMed ID: 30587400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [11C]DASB.
    Bhagwagar Z; Murthy N; Selvaraj S; Hinz R; Taylor M; Fancy S; Grasby P; Cowen P
    Am J Psychiatry; 2007 Dec; 164(12):1858-65. PubMed ID: 18056241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging serotonergic transmission with [11C]DASB-PET in depressed and non-depressed patients infected with HIV.
    Hammoud DA; Endres CJ; Hammond E; Uzuner O; Brown A; Nath A; Kaplin AI; Pomper MG
    Neuroimage; 2010 Feb; 49(3):2588-95. PubMed ID: 19853044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography.
    Cannon DM; Ichise M; Fromm SJ; Nugent AC; Rollis D; Gandhi SK; Klaver JM; Charney DS; Manji HK; Drevets WC
    Biol Psychiatry; 2006 Aug; 60(3):207-17. PubMed ID: 16875929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: a [11C]DASB PET study.
    Reimold M; Batra A; Knobel A; Smolka MN; Zimmer A; Mann K; Solbach C; Reischl G; Schwärzler F; Gründer G; Machulla HJ; Bares R; Heinz A
    Mol Psychiatry; 2008 Jun; 13(6):606-13, 557. PubMed ID: 18268503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Midbrain serotonin transporter binding potential measured with [11C]DASB is affected by serotonin transporter genotype.
    Reimold M; Smolka MN; Schumann G; Zimmer A; Wrase J; Mann K; Hu XZ; Goldman D; Reischl G; Solbach C; Machulla HJ; Bares R; Heinz A
    J Neural Transm (Vienna); 2007; 114(5):635-9. PubMed ID: 17225932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [(11)C]DASB and (S,S)-[(18)F]FMeNER-D(2).
    Nogami T; Takano H; Arakawa R; Ichimiya T; Fujiwara H; Kimura Y; Kodaka F; Sasaki T; Takahata K; Suzuki M; Nagashima T; Mori T; Shimada H; Fukuda H; Sekine M; Tateno A; Takahashi H; Ito H; Okubo Y; Suhara T
    Int J Neuropsychopharmacol; 2013 Jun; 16(5):937-43. PubMed ID: 23067569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A positron emission tomography study of the serotonergic system in relation to anxiety in depression.
    Iscan Z; Rakesh G; Rossano S; Yang J; Zhang M; Miller J; Sullivan GM; Sharma P; McClure M; Oquendo MA; Mann JJ; Parsey RV; DeLorenzo C
    Eur Neuropsychopharmacol; 2017 Oct; 27(10):1011-1021. PubMed ID: 28811068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients.
    Oz MD; Baskak B; Uckun Z; Artun NY; Ozdemir H; Ozel TK; Ozguven HD; Suzen HS
    Pharmacogenomics J; 2020 Jun; 20(3):443-450. PubMed ID: 31792367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common HTR2A variants and 5-HTTLPR are not associated with human in vivo serotonin 2A receptor levels.
    Spies M; Nasser A; Ozenne B; Jensen PS; Knudsen GM; Fisher PM
    Hum Brain Mapp; 2020 Nov; 41(16):4518-4528. PubMed ID: 32697408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography.
    Voineskos AN; Wilson AA; Boovariwala A; Sagrati S; Houle S; Rusjan P; Sokolov S; Spencer EP; Ginovart N; Meyer JH
    Psychopharmacology (Berl); 2007 Sep; 193(4):539-45. PubMed ID: 17497139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo serotonin transporter and 1A receptor binding potential and ecological momentary assessment (EMA) of stress in major depression and suicidal behavior.
    Bartlett EA; Zanderigo F; Stanley B; Choo TH; Galfalvy HC; Pantazatos SP; Sublette ME; Miller JM; Oquendo MA; Mann JJ
    Eur Neuropsychopharmacol; 2023 May; 70():1-13. PubMed ID: 36780841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain serotonin transporter binding, plasma arachidonic acid and depression severity: A positron emission tomography study of major depression.
    Gopaldas M; Zanderigo F; Zhan S; Ogden RT; Miller JM; Rubin-Falcone H; Cooper TB; Oquendo MA; Sullivan G; Mann JJ; Sublette ME
    J Affect Disord; 2019 Oct; 257():495-503. PubMed ID: 31319341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.